This week’s highlights: orforglipron, an oral small-molecule candidate, produced dose-dependent weight loss comparable to injectable GLP-1 drugs; lupus patients show a ~25× higher rate of EBV-infected B cells; Perseverance found an 80 cm iron-nickel meteorite on Mars; a topical insulin cream normalized glucose in mice for about 12 hours; and three astronauts await retrieval after orbital debris damaged a return vehicle. Researchers also identified brain-circuit changes in Alzheimer’s that may be protectable to preserve social memory.
This Week in Science: Oral Ozempic Alternative, Insulin Skin Cream, Mars Meteorite and More

Similar Articles

Single‑Shot GLP‑1 Gene Therapies: Could One Injection Replace Ozempic?
Two biotech startups—RenBio and Fractyl—are developing gene‑based therapies to make patients’ cells produce GLP‑1, the hormon...

Daily Oral GLP‑1 Pill Cuts About 10% of Body Weight in 18 Months, Study Finds
Trial results: Orforglipron, an investigational oral GLP‑1, produced about 10% average body‑weight loss after 72 weeks in adu...

This Week in Science: Possible Diabetes Cure in Mice, Ancient Moon Sulfur, a New Branch of Life, and More
This week’s science highlights include a functional cure for type 1 diabetes in mice using immune reboot and stem cell transp...

Low-dose Ozempic-like Drug Produces ‘Younger’ Molecular Profile in Mice — Human Effects Unknown
Researchers treated middle-aged mice with low-dose exenatide, a GLP-1 receptor agonist similar in action to semaglutide, for ...

Needle-Free Ozempic? Daily Semaglutide Pill Nearly Matches Wegovy Injection in Major Trial
Bottom line: A 71-week, double-blind trial of 307 participants found a once-daily 25 mg oral semaglutide pill produced an ave...

Gut Microbe and Its Metabolite May Trigger an Ozempic‑Like GLP‑1 Response — A Potential Natural Way to Curb Sugar Cravings
Researchers at Jiangnan University report that the gut bacterium Bacteroides vulgatus and one of its metabolites increased GL...

WHO: Weight‑loss Injections Can Help — But They Won’t Solve the Global Obesity Crisis
The WHO says injectable GLP‑1 drugs (liraglutide, semaglutide, tirzepatide) can support weight loss in adults but are not a s...

Metformin’s Brain Link: Study Shows Rap1 in the Ventromedial Hypothalamus Is Required for Its Glucose-Lowering Effect in Mice
The study in Science Advances shows that metformin reaches the ventromedial hypothalamus and suppresses a brain protein calle...

After 60 Years, Metformin Found to Act Directly on the Brain — Mouse Study Reveals New Pathway
Researchers report that metformin reaches the ventromedial hypothalamus (VMH) in mice and suppresses the Rap1 protein, improv...

Killing 'Zombie' Blood-Vessel Cells Restores Glucose Control in Mice — Early Study Suggests New Diabetes Strategy
The study identifies senescent endothelial (“zombie”) cells in blood-vessel linings as drivers of metabolic dysfunction in mi...
Novo Nordisk Cuts Cash Prices for Wegovy and Ozempic — $199 Intro Offer; Self‑Pay Drops to $349
Novo Nordisk will offer Wegovy (0.25 mg and 0.5 mg) and Ozempic to new self‑pay patients at $199/month for the first two months through March 31, 2026. After the introductory ...

Goodbye to Finger Pricks: MIT’s Light-Based Glucose Monitor Shrinks Toward Watch Size
MIT researchers report progress on a noninvasive, light-based glucose monitor that could replace finger pricks and implanted ...

States Pull Back Medicaid Coverage for GLP-1 Weight-Loss Drugs as Costs Bite
Many states are cutting or tightening Medicaid coverage for GLP-1 weight-loss drugs amid rising costs and federal policy chan...

Two FDA-Approved Cancer Drugs, Combined, Reduce a Key Alzheimer’s Protein in Mice — 1.4M Health Records Helped Point the Way
UCSF researchers used gene-expression screening and 1.4 million anonymized health records to repurpose existing drugs for Alz...

Experimental Compound Blocks RAGE–DIAPH1 Pathway, Reduces Inflammation and Speeds Wound Healing in Diabetic Models
Study: An experimental compound blocks the RAGE–DIAPH1 interaction, lowering inflammation and improving wound healing in diab...

Psilocybin Metabolite Shows Promise in Slowing Cellular Aging — Early Cell and Mouse Studies
Dr. Louise Hecker and colleagues at Baylor report that psilocin, the active metabolite of psilocybin, extended cellular lifes...

Scientists Turn Positive Memories On and Off in Mice — Could That Help Treat Anxiety?
Steve Ramirez recounts experiments showing that optogenetic reactivation of positive hippocampal memory traces in mice can ra...

Breakthrough in Mice: Type 1 Diabetes Reversed by Immune Reset and Donor Cell Transplants
Stanford researchers reversed type 1 diabetes in mice by combining a mild immune-conditioning regimen with bone marrow stem-c...

Tirzepatide Quieted 'Food Noise' in a Brain-Recorded Case — Effect Wore Off After Several Months
This small brain-recording case followed a 60-year-old woman with obesity and loss-of-control eating who was taking tirzepati...

This Week in Science: Spectacular Auroras, 'Morse' Bees, Coffee & the Secret to Winning Rock‑Paper‑Scissors
This week's science roundup covers several standout items: a rare triple solar eruption produced auroras visible as far south...
